These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3987834)

  • 1. Animal models for evaluating the myelosuppressive effects of cancer chemotherapeutic agents.
    Schurig JE; Schlein A; Florczyk AP; Farwell AR; Bradner WT
    Exp Hematol; 1985; 13 Suppl 16():101-5. PubMed ID: 3987834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mouse as a model for predicting the myelosuppressive effects of anticancer drugs.
    Schurig JE; Florczyk AP; Bradner WT
    Cancer Chemother Pharmacol; 1986; 16(3):243-6. PubMed ID: 3698166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice.
    Akahori H; Shibuya K; Ozai M; Ida M; Kabaya K; Kato T; Miyazaki H
    Stem Cells; 1996 Nov; 14(6):678-89. PubMed ID: 8948025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of myelosuppressive xenobiotics.
    Pessina A; Albella B; Bayo M; Bueren J; Brantom P; Casati S; Croera C; Gagliardi G; Foti P; Parchment R; Parent-Massin D; Schoeters G; Sibiril Y; Van Den Heuvel R; Gribaldo L
    Toxicol Sci; 2003 Oct; 75(2):355-67. PubMed ID: 12883091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy.
    Blumenthal RD; Lew W; Juweid M; Alisauskas R; Ying Z; Goldenberg DM
    Cancer; 2000 Jan; 88(2):333-43. PubMed ID: 10640965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human interleukin-11 improved carboplatin-induced thrombocytopenia without affecting antitumor activities in mice bearing Lewis lung carcinoma cells.
    Saitoh M; Taguchi K; Momose K; Suga K; Yamazaki N; Ono C; Suzuki T; Takeuchi O; Yasuda S; Miyata K
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):161-6. PubMed ID: 11862431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of hematologic toxicity of antineoplastic agents with their effects on bone marrow stem cells: interspecies studies using an in vivo assay.
    Marsh JC
    Exp Hematol; 1985; 13 Suppl 16():16-22. PubMed ID: 3987835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of cytotoxic agents on hematopoietic progenitors.
    Botnick LE; Hannon EC; Vigneulle R; Hellman S
    Cancer Res; 1981 Jun; 41(6):2338-42. PubMed ID: 7237432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells.
    OKunewick JP; Buffo MJ; Kociban DL
    Exp Hematol; 1985; 13 Suppl 16():23-30. PubMed ID: 3987836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C (MMC)-induced myelosuppressive mice.
    Hai-Yang G; Ping S; Li JI; Chang-Hong X; Fu T
    J Exp Ther Oncol; 2004 Oct; 4(3):181-7. PubMed ID: 15724837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Protection of hematopoietic cells against toxicity of anticancer agents by transfecting mdr1 gene into bone marrow cells].
    Chen L; Liu Y
    Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):456-9. PubMed ID: 11235562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic safety and tolerability of topotecan in recurrent ovarian cancer and small cell lung cancer: an integrated analysis.
    Armstrong DK; Spriggs D; Levin J; Poulin R; Lane S
    Oncologist; 2005 Oct; 10(9):686-94. PubMed ID: 16249347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of oral mucosal neutrophil counts to detect the onset and resolution of profound neutropenia following high-dose myelosuppressive chemotherapy.
    Akpek G; Knight RD; Wright DG
    Am J Hematol; 2003 Jan; 72(1):13-9. PubMed ID: 12508262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of imidazole antifungal agents on colony formation by murine bone marrow CFUc (colony forming units in culture].
    Benkó I; Megyeri A; Hernádi F; Kovács P
    Acta Pharm Hung; 1996 Nov; 66(6):241-5. PubMed ID: 9604489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs and the bone marrow.
    Treleaven J; Barrett J
    Br J Hosp Med; 1990 Oct; 44(4):245-50. PubMed ID: 2249099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.
    Broxmeyer HE; Pelus LM; Kim CH; Hangoc G; Cooper S; Hromas R
    Exp Hematol; 2006 Aug; 34(8):1069-77. PubMed ID: 16863913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of cyclophosphamide induced neutropenia by hypertransfusion and androgen therapy.
    DiBenedetto J; Higby DJ; Chester SJ; Albala MM
    J Med; 1980; 11(5-6):385-92. PubMed ID: 6962825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.